OTCPK:CKLSF (Hong Kong)
Â
$
0.090
+0.020 (+28.57%)
10:08 PM EST
Business Description
CK Life Sciences International Holdings Inc
ISIN : KYG2176J1058
Total Employee Number:
1,920Description
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.75 | |||||
Debt-to-EBITDA | 19.78 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.18 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.8 | |||||
3-Year EBITDA Growth Rate | -6.3 | |||||
3-Year Book Growth Rate | -3.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 28.57 | |||||
12-1 Month Momentum % | 28.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.87 | |||||
Quick Ratio | 0.51 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 116.27 | |||||
Days Sales Outstanding | 66.05 | |||||
Days Payable | 50.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -8.58 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 29.15 | |||||
Operating Margin % | -2.42 | |||||
Net Margin % | -3.45 | |||||
EBITDA Margin % | 6.19 | |||||
FCF Margin % | 3.47 | |||||
OCF Margin % | 3.47 | |||||
ROE % | -5.12 | |||||
ROA % | -1.65 | |||||
ROIC % | -1.27 | |||||
3-Year ROIIC % | -348.98 | |||||
ROC (Joel Greenblatt) % | 6.22 | |||||
ROCE % | 2.87 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shiller PE Ratio | 50.14 | |||||
PS Ratio | 1.15 | |||||
PB Ratio | 1.65 | |||||
Price-to-Tangible-Book | 9 | |||||
Price-to-Free-Cash-Flow | 34.21 | |||||
Price-to-Operating-Cash-Flow | 34.21 | |||||
EV-to-EBIT | 49.55 | |||||
EV-to-EBITDA | 36.84 | |||||
EV-to-Revenue | 2.28 | |||||
EV-to-FCF | 65.96 | |||||
Price-to-GF-Value | 0.9 | |||||
Price-to-Projected-FCF | 1.5 | |||||
Price-to-Median-PS-Value | 0.9 | |||||
Earnings Yield (Greenblatt) % | 2.02 | |||||
FCF Yield % | 2.99 | |||||
Forward Rate of Return (Yacktman) % | 1.36 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CKLSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CK Life Sciences International Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 692.438 | ||
| EPS (TTM) ($) | -0.002 | ||
| Beta | -0.0205 | ||
| 3-Year Sharpe Ratio | 0.32 | ||
| 3-Year Sortino Ratio | 4.37 | ||
| Volatility % | 28.57 | ||
| 14-Day RSI | 100 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.09 | ||
| 12-1 Month Momentum % | 28.57 | ||
| 52-Week Range ($) | 0.07 - 0.09 | ||
| Shares Outstanding (Mil) | 9,611.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CK Life Sciences International Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CK Life Sciences International Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
CK Life Sciences International Holdings Inc Frequently Asked Questions
What is CK Life Sciences International Holdings Inc(CKLSF)'s stock price today?
The current price of CKLSF is $0.09. The 52 week high of CKLSF is $0.09 and 52 week low is $0.07.
When is next earnings date of CK Life Sciences International Holdings Inc(CKLSF)?
The next earnings date of CK Life Sciences International Holdings Inc(CKLSF) is .
Does CK Life Sciences International Holdings Inc(CKLSF) pay dividends? If so, how much?
CK Life Sciences International Holdings Inc(CKLSF) does not pay dividend.
Guru Commentaries on OTCPK:CKLSF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CK Life Sciences International Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers